CADENCE CAPITAL MANAGEMENT LLC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2020$493,000
-76.1%
26,900
-76.7%
0.12%
-60.2%
Q2 2020$2,059,000
+14.9%
115,309
+4.4%
0.30%
-1.6%
Q1 2020$1,792,000
-14.3%
110,494
-4.9%
0.30%
+34.5%
Q4 2019$2,092,000
-20.6%
116,212
-10.6%
0.23%
-39.6%
Q3 2019$2,634,000129,9920.37%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q3 2019
NameSharesValueWeighting ↓
CM Management, LLC 200,000$1,448,0001.54%
Tri Locum Partners LP 376,486$2,726,0001.12%
Perceptive Advisors 3,645,471$26,393,0000.83%
TANG CAPITAL MANAGEMENT LLC 750,000$5,430,0000.82%
Bridge City Capital, LLC 162,146$1,174,0000.62%
Knott David M Jr 186,134$1,348,0000.57%
Aristotle Capital Boston, LLC 2,322,168$16,812,0000.50%
Phocas Financial Corp. 316,455$2,291,0000.34%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$22,644,0000.30%
Temasek Holdings (Private) Ltd 7,381,116$53,439,2800.29%
View complete list of COHERUS BIOSCIENCES INC shareholders